Skip to main content
. 2017 May 3;15(6):4005–4014. doi: 10.3892/mmr.2017.6546

Figure 6.

Figure 6.

Effects of SFN on the protein and gene expression of HO-1 and NQO1 in BLM-induced models. (A) Western blot analysis for HO-1 and NQO1 was used to investigate the effect of SFN on BLM induced models at days 7 and 28 post-treatment. BLM reduced the protein levels of HO-1 and NQO1 at days 7 and 28, and this was reversed by SFN treatment. (B) Quantification of mRNA expression levels of HO-1 and NQO1 in BLM induced lung tissues at day 7 and 28 post-treatment, as detected by reverse transcription-quantitative polymerase chain reaction. Data are presented as the mean ± standard deviation (n=6/group). #P<0.05 vs. control group; *P<0.05 vs. BLM group. BLM, bleomycin; SFN, sulforaphane; Ctrl, control; HO-1, heme oxygenase-1; NQO1, nicotinamide adenine dinucleotide phosphate quinone oxidoreductase.